ABSTRACT
Introduction
Breast cancer is the most common cancer among women in South Africa, and indeed in women worldwide (Herbst, 2014 ; International Agency for Research on Cancer, 2012). Therefore breast cancer places a significant monetary and human resource burden on the health system. Different parts of the world have different preferred methods of diagnosis, but the triple assessment method of diagnosis is most widely accepted. Triple assessment uses three separate tools to diagnose malignancy, namely clinical examination, radiological imaging (mammography and/or ultrasound) and pathology (fine needle aspirate cytology (FNAC) or core needle biopsy (CNB)). When all three diagnostic tools are used, diagnostic accuracy is almost 100% (Berner et al., 2003:344) . The preference of FNAC or CNB in initial diagnosis is the major difference in the triple assessment in different parts of the world. In many western countries (such as the USA, Canada and the UK) CNB is preferred, while other parts of Europe and many developing countries (including South Africa) still favour using FNAC (Challa, 2013:1) .
The Breast Clinic was started at Groote Schuur Hospital in 1951 in order to streamline the treatment of patients with breast cancer (Department of Surgery, 1996) . In 1982, cytology was introduced into the outpatient clinic, which allowed for rapid on site evaluation of FNAs (fine needle aspirate) (Learmonth et al., 1987:525) . In 2014, fine needle aspiration is still the favoured methodology at
The Breast Clinic as an essential part of the triple assessment. At The Breast Clinic, an aspirate is prepared in two ways: air-dried and stained using the Giemsa stain, and fixed and stained using the Papanicolaou stain. Each aspirate is checked by numerous people before a definitive diagnosis is made. First, by a senior cytotechnologist at the clinic; then by a pathology registrar, who subsequently checks the diagnosis with a consultant. The case may also be discussed at a meeting with a multidisciplinary team.
According to previous research, there are various reasons why FNAC should be used, and various other reasons that it is not reliable enough in diagnosing breast lesions. FNAC is extremely reliable in distinguishing benign lesions from those that are malignant, however it is not able to subcategorise those lesions (Learmonth et al., 1987:525) . In order to further categorise a lesion, histology must to be used. Cytology also cannot be accurately used to assess the receptor status of a malignant tumour; histology is used for this purpose (Willems, van Deurzen & van Diest, 2012:287) . Successful cytological diagnosis of FNAs depends largely on the skill and experience of the clinician performing the FNA. It is essential that clinical details of the patient are known to the clinician performing the aspirate and also to the cytotechnologist or pathologist evaluating the aspirate (Learmonth et al., 1987:525 malignancies on cytology, and four on histology. There was 1 false positive for males, which, on histology, was found to be gynaecomastia.
Materials and methods

An
The minimum age of the patients was 8 years and the maximum was 98. In the dataset, there were 49 false negative and 8 false positive cytological results. The overall false negative rate was 2.51% and the false positive rate was 0.41%. The false negative rate may be due to geographical misses when sampling the lesion. The false negative rate may be due to incorrect evaluation of the aspirate. Because of the false positives and false negatives that may be encountered, it is essential that histological confirmation of the cytological result be obtained before starting treatment in order to prevent over treatment of patients (Learmonth et al., 1987 :525).
The average age of patients that had FNA was 45.21 years old. The median and mode were both 44. This shows that younger women are coming into the clinic. It may be that women are getting cancer at younger ages. The possible changing age profile of breast cancer patients could be analysed in future research. Programmes may need to be tailored to younger women if women are getting breast cancer at earlier ages.
Conclusion
In conclusion, it is hoped that this research can be used for better planning of the GSH Breast Clinic. Furthermore, it is clear that The Breast Clinic plays an important role in screening for and the treatment of breast cancer in Cape Town.
This research could also be used for the planning of future walk-in breast clinics in other areas of Cape Town and South Africa, as the GSH Breast Clinic is efficient and effective in accomplishing its mission. In order to make it even more effective, the inadequacy rate of FNAs need to be addressed, through regular training of clinicians and pathologists, and the implementation of ultrasound guided FNAC. It is also important to recognise the strengths and limitations of FNAC. FNAC is very effective at distinguishing between malignant and benign lesions, but it is less effective at further classifying the lesions. It is important for clinicians and pathologists to use their discretion when deciding whether to perform more invasive procedures after receiving the results of the FNA, and to use CNB in a way that compliments FNAC.
